COMPOSITION (per ml): 
XYLAZINE BASE(as HYDROCHLORIDE)                  20 mg
                     
PHARMACOLOGICAL PROPERTIES:
XYLAZINE 20 includes hydrochloride xylazine , that belongs at a2 adrenergic stimulators. Its action is due to its ability to stimulate the a2 adrenergic receptor. Xylazine is an exquisite and secure tranquillizer and analgetic, if attention is paid to the pharmacological properties of the different species of animals. The tranquillizing, muscle-relaxing and analgetic qualities of xylazine are due to its action on the autonomic and central neural system. The analgesia and the tranquillizing action produced by xylazine are independent of the dosage and can last up to 1-2 hours. If the injection is intramuscularly, then its action begins after 5-15 minutes, and if the injection is intravenously, begins after 5 minutes.An extra quality of xylazine is the  intense synergia with all the tranquillizers, relieves, cataleptic and anesthesia medicines.

TARGET SPECIES
Dogs, cats.

INDICATIONS:
In all cases that tranquillizing dosage is required (as restraining, transportation, sedation during small operations, e.t.c). It is also used to provoke muscle-relaxation and analgesia and for preanesthesia.

SPECIALS PRECAUTIONS:
Do not administer at races of dogs that is possible to suffer by gastric dilatation ( Great Dane, Irish Setter, Basset Hound)Also, it  is recommende the simultaneous administration of atropine at half , after the administration of xylazine. At dogs, the tension of vomit is reduced when the injection is done intravenously.  

USE DURING PREGNANCY AND LACTATION:
The administration of the product should be avoided during pregnancy at last stage.
 
INTERACTIONS WITH OTHER MEDICAMENTS:
It should not be administered in combination with neuroleptic or tranquillizers.
More repression is noticed when xylazine is administered with varvituric.The administration of varvituric for anesthesia , should be done in a reduced dosage and injected slowly intravenous.

ADMINISTRATION AND ROUTE OF ADMINISTRATION:

Dog:
Intramuscularly or intravenously: 1-3 mg per kg (0,5-1,5ml/10 kg of body weight)
 Preanesthesia:0, 5-1,1 mg per kg (0,3-0,5mlper 10 kg of body weight)
 When it is combined with ketamine 2 mg per kg (1ml per 10 kg of body weight) with 6-10 mg per kg of ketamine
Cat:
 Intramuscularly or subcutaneous: 1-3 mg per kg (0,05-0,15 ml per kg of body weight)
 For the preanesthesia: 1 mg per kg (0,05 ml per kg)

 
WITHDRAWAL PERIOD:
Is not required.

CONTRA INDICATIONS:
Do not administer during the last stage of pregnancy, to animals with pulmonary or cardiovascular diseases .Do not administer to dogs or cats with protrusion, blocking of esophagus or gastric version (because it is possible to cause vomit, that is usual to cats)

SHELF LIFE
2 years at temperature room.

PACKING:
Vials of 20 ml, 50 ml

FOR VETERINARY USE ONLY
KEEP AWAY FROM CHILDREN.                           
Á.Ì.Ê: 19506/29-6-1992/K-2488